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CNS Complications ofMalignantDisease.
(Eds) J. M. A. WHITEHOUSE & H. E. M.
KAY (1979). London: Macmillan. 419 pp.
£20.00.
With improvements in the management of
malignant disease, and with the increased
survival rates which are becoming more
frequent in many types of tumour, so the
importance of complications of treatment
increases. The quality oflife andthe long-term
consequences of treatment are now problems
of paramount importance in several forms
of cancer. This book, the report of a Sym-
posium held in Southampton in 1978,
summarizes these problems in relation to the
central nervous system. As such it is a first
class survey of the state of the art at the
present time.
The first three sections deal with meningeal
infiltration of the central nervous system in
the leukaemias and the lymphomas. There
are some excellent reviews in this part of
the book, well referenced, making good
background reading in the subject. There is
a short section on spinal-cord compression,
though it is perhaps a pity that this was
restricted only to myeloma. Two papers
are presented on the involvement of the CNS
by small-cell carcinoma of the bronchus.
From the point of view of long-term
complications, perhaps the most significant
section of the book is concerned with growth
and intellectual development following treat-
ment of CNS disease. Once again excellent
review papers are presented. Infections of
the CNS receive good coverage, as do dia-
gnostic aspects of CNS infiltration.
The remaining parts of the book deal with
the use of surgery, radiotherapy and chemo-
therapy in the treatment of primary and
secondary malignant disease of the brain.
Because of the particular pharmacological
problems of the blood-brain barrier this
aspect is well covered.
In summary this is a comprehensive and
up-to-date account of CNS complications of
malignant disease, with the only real omission
being a review of the non-metastatic com-
plications of malignancy involving the
CNS.
K. C. CALMAN
Cancer Chemotherapy 1979. EORTC
CancerChemotherapy Annual 1. (Ed) H.
M. PINEDO (1979). Netherlands: Excerpta
Medica. 511 pp. US$73.
This book represents the first in a nem
series of annual reviews on Cancer Chemo-
therapy edited on behalf of the EORTC
group by Professor Pinedo. In the first
section of the book a comprehensive update
is given of the recent advances in cancer
chemotherapy, relating specifically to indivi-
dual drugs, and this section of the book
concludes with an evaluation of some of
the new drugs that have become available in
the past 2 years.
The second section of the book provides
a summary of the present status of chemo-
therapy in specific diseases, and outlines the
recent advances. In general the sections on
individual diseases are very well covered, and
most authors have managed, in a short space,
to comprehensively cover the recent litera-
ture.
This reviewer has very few criticisms of
this first annual review of chemotherapy by
the EORTC group. In general the individual
chapters are succinct, relevantandup-to-date,
as well as being critical of the available data
in most areas of chemotherapy. A further
important feature is the comprehensive nature
of the bibliography associated with many of
thechapters,which will considerably facilitate
the individual reader's approach to specific
areas of research. Clearly a volume such as
this will have to be regularly up-dated, but
there is no doubt that the editor of the first
volume has set very high standards, both in
his choice of individual authors and in the
overall presentation of the book. It can be
thoroughly recommended for trainees in
clinical oncology, particularly medical
oncology, and for the specialist medical
oncologist who requires an easily digestible
update. It may also be of value to more
basic scientists who wish to review areas of
interesting clinical research in specific diseases
and with specific chemotherapeutic agents
and, as such, should find a place, not only
in institutional libraries, but in personal
libraries as well.
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